The deal is structured as a private investment in a public equity and includes an equity stake in Absci. AMD didn’t disclose the amount of its stake. AMD, which is based in Santa Clara ...

Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug discovery workloads, including a biologic drug design platform using ...

Absci management will webcast a corresponding ... we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against other AI stocks. As per a CNBC report, in 2025 ...

Strategic partnerships, like those with AMD and AstraZeneca, validate Absci's platform but have yet to generate significant revenue. ABSI stock's current valuation reflects fear more than fact ...

7 analysts have expressed a variety of opinions on Absci (NASDAQ:ABSI) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their ...

Absci management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its business developments, financial and operating results ...

Shares of NASDAQ ABSI opened at $3.09 on Wednesday. Absci has a 52 week low of $2.01 and a 52 week high of $6.33. The company has a quick ratio of 5.63, a current ratio of 5.63 and a debt-to ...

(MENAFN- GlobeNewsWire - Nasdaq) VANCOUVER, Wash. and NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today ...

Short interest in Absci Corp (NASDAQ:ABSI) increased during the last reporting period, rising from 18.83M to 20.57M. This put 22.75% of the company's publicly available shares short. Short ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...